View a ticker or compare two or three
BMRN
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

BMRN is expected to report earnings to fall 48.18% to 36 cents per share on July 30

BioMarin Pharmaceutical BMRN Stock Earnings Reports
Q2'24
Est.
$0.37
Q1'24
Beat
by $0.39
Q4'23
Beat
by $0.29
Q3'23
Beat
by $0.23
Q2'23
Beat
by $0.31
The last earnings report on April 24 showed earnings per share of 70 cents, beating the estimate of 31 cents. With 838.40K shares outstanding, the current market capitalization sits at 16.31B.
A.I. Advisor
published General Information

General Information

a developer of innovative pharmaceuticals for serious diseases & medical conditions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
770 Lindaro Street
Phone
+1 415 506-6700
Employees
3401
Web
https://www.biomarin.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ANDE52.242.11
+4.21%
Andersons
LND5.040.11
+2.23%
BrasilAgro - Companhia Brasileira de Propriedades Agricolas
NOV19.47-0.04
-0.21%
NOV
BIFI.X335.057430-7.234039
-2.11%
Beefy cryptocurrency
LPTX2.18-0.06
-2.68%
Leap Therapeutics

BMRN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with SRPT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
-1.43%
SRPT - BMRN
45%
Loosely correlated
-1.40%
AXON - BMRN
42%
Loosely correlated
-0.52%
FGEN - BMRN
41%
Loosely correlated
-6.14%
FOLD - BMRN
40%
Loosely correlated
-2.21%
IONS - BMRN
36%
Loosely correlated
-3.77%
More